Advertisement

Topics

Extension to drug discovery alliance announced

09:58 EDT 21 Aug 2017 | EPM Magazine

A strategic alliance between Cancer Research UK, Newcastle University and Astex Pharmaceuticals for drug discovery has been extended for another three years.

Original Article: Extension to drug discovery alliance announced

NEXT ARTICLE

More From BioPortfolio on "Extension to drug discovery alliance announced"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...